Author | Whitney J. Palmer


Nurse Practitioner Q&A: Screen Risk Factors for Blood Clot Disorder

December 11, 2019

Blood clots can cause critical or lethal problems in patients, and individuals with antiphospholipid syndrome can experience these events at any location in their bodies. However, there’s not a great deal of clarity on which risk factors are most significant for this condition. In this Q&A, we feature a conversation with Eileen J. Lydon, ANP-BC, a rheumatology nurse practitioner at New York University Langone Orthopedic Hospital, who recently spoke on recommendations for treating patients with antiphospholipid syndrome.

Sarilumab Shows Efficacy in Controlling Blood Glucose Levels for Rheumatoid Arthritis Patients with Diabetes

October 08, 2019

Patients with rheumatoid arthritis and diabetes saw greater improvement in blood glucose levels with sarilumab than adalimumab or placebo, shows a study spresented at Clinical Congress of Rheumatology West held in San Diego last month.

Tofacitinib Improves Quality of Life Indicators in Psoriatic Arthritis Study

October 08, 2019

A clinical trial presented at the Clinical Congress of Rheumatology West in San Diego last month shows that the oral JAK inhibitor tofacitinib improved the signs, symptoms and quality of life for patients with psoriatic arthritis who have not had an adequate response to DMARDs or TNF inhibitors.

Filgotinib Trial Shows Efficacy for Ankylosing Spondylitis

October 08, 2019

The oral therapy filgotinib could be a more effective treatment for patients with active ankylosing spondylitis who fail treatment with NSAIDs, according to the results of a study presented at the Clinical Congress of Rheumatology West in San Diego last month.